4//SEC Filing
GRANADILLO PEDRO P 4
Accession 0001140361-24-030724
CIK 0001281895other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:10 PM ET
Size
7.4 KB
Accession
0001140361-24-030724
Insider Transaction Report
Form 4
GRANADILLO PEDRO P
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-13+23,944→ 23,944 totalExercise: $22.86Exp: 2034-06-13→ Common Stock (23,944 underlying) - Award
Stock Option (Right to Buy)
2024-06-13$15.04/sh+4,655$70,011→ 4,655 totalExercise: $22.86Exp: 2034-06-13→ Common Stock (4,655 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025.
- [F2]This option represents a right to purchase a total of 4,655 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001217544
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:10 PM ET
- Size
- 7.4 KB